RxSight (RXST) shares were down more than 12% in recent Friday trading after Stifel downgraded the company's stock to hold from buy and cut its price target to $40 from $65.
Trading volume stood at about 1.5 million shares against a daily average of about 580,000 shares.
Price: 33.38, Change: -4.81, Percent Change: -12.59